Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PYC THERAPEUTICS LIMITED Director's Dealing 2010

Dec 16, 2010

65640_rns_2010-12-16_b4a9eecb-2d47-4733-97ad-971b6efff8c9.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y

Change of Director’s Interest Notice

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director JOHN DOUGLAS WILSON
Date of last notice 5 November 2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest INDIRECT
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
MAINZ CONSULTANTS LTD
GILLESPIE NOMINEES LTD
DIRECTOR AND SHAREHOLDER
Date of change 16 DECEMBER 2010
No. of securities held prior to change INDIRECT
300,000 UNLISTED OPTIONS
618,337 ESOP OPTIONS
10,000 CONVERTIBLE NOTES
Class ESOP OPTIONS
Number acquired 500,000
Number disposed NIL
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
NIL
No. of securities held after change INDIRECT
300,000 UNLISTED OPTIONS
1,118,337 ESOP OPTIONS
10,000 CONVERTIBLE NOTES
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
APPROVED BY SHAREHOLDERS AT
GENERAL MEETING ON 30 NOVEMBER
2010

1

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

2

  • See chapter 19 for defined terms.

Appendix 3Y Page

11/3/2002

Appendix 3Y

Change of Director’s Interest Notice

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director NICHOLAS WOOLF
Date of last notice 4 OCTOBER 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest DIRECT
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change 16 DECEMBER 2010
No. of securities held prior to change 600,000 SHARES
Class ORDINARY SHARES AND ESOP
OPTIONS
Number acquired 524,500 SHARES
1,400,000 ESOP OPTIONS
Number disposed NIL
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
8 CENTS PER SHARE
NIL PER ESOP OPTION
No. of securities held after change 1,124,500 SHARES
1,400,000 ESOP OPTIONS
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
APPROVED BY SHAREHOLDERS AT
GENERAL MEETING ON 30 NOVEMBER
2010

1

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

2

  • See chapter 19 for defined terms.

Appendix 3Y Page

11/3/2002